Silo Pharma (SILO) Long-Term Investments (2018 - 2022)
Silo Pharma (SILO) posted Long-Term Investments of $77939.0 for Q3 2022, down 81.44% sequentially from $419995.0 in Q4 2021, and down 90.5% YoY from $820126.0 in Q3 2021.
Silo Pharma (SILO) Long-Term Investments (2018 - 2022) Analysis & Trends
Silo Pharma has reported Long-Term Investments for 5 years, with the latest figure at $77939.0 in Q3 2022.
- Quarterly Long-Term Investments fell 90.5% year-over-year to $77939.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $77939.0 (down 90.5% YoY) and the FY2021 annual result came in at $419995.0, up 209897.5% from the prior year.
- Long-Term Investments fell to $77939.0 in Q3 2022 per SILO's latest filing, from $419995.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $820126.0 in Q3 2021 and troughed at $200.0 in Q4 2020.
- A 5-year average of $172419.7 and a median of $12766.0 in 2018 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2020 and 2021: Long-Term Investments slumped 97.87% in 2020, then soared 209897.5% in 2021.
- Over 5 years, Long-Term Investments stood at $12766.0 in 2018, then decreased by 26.41% to $9394.0 in 2019, then plunged by 97.87% to $200.0 in 2020, then jumped by 209897.5% to $419995.0 in 2021, then plunged by 81.44% to $77939.0 in 2022.
- According to Business Quant data, Long-Term Investments over the past three periods registered $77939.0, $419995.0, and $820126.0 for Q3 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 77,939.00 |
| Dec 31, 2021 | 419,995.00 |
| Sep 30, 2021 | 820,126.00 |
| Jun 30, 2021 | 600,000.00 |
| Mar 31, 2021 | 570,000.00 |
| Dec 31, 2020 | 200.00 |
| Sep 30, 2020 | 9,394.00 |
| Jun 30, 2020 | 9,394.00 |
| Mar 31, 2020 | 9,394.00 |
| Dec 31, 2019 | 9,394.00 |
| Sep 30, 2019 | 9,394.00 |
| Jun 30, 2019 | 12,766.00 |
| Mar 31, 2019 | 12,766.00 |
| Dec 31, 2018 | 12,766.00 |
| Sep 30, 2018 | 12,767.00 |